Recordati Updates on Share Buyback Program Progress

Recordati Industria Chimica e Farmaceutica SPA ( (IT:REC) ) has provided an announcement.

Recordati has updated its shareholders on the progress of its share buyback program, which was initiated to support stock options and performance share plans for its management. Between March 3 and March 7, 2025, the company purchased 139,592 of its ordinary shares, holding a total of 2,942,785 own shares, equivalent to 1.407% of its share capital. This move is part of Recordati’s strategy to enhance shareholder value and align management incentives with company performance.

More about Recordati Industria Chimica e Farmaceutica SPA

Recordati Industria Chimica e Farmaceutica S.p.A. is an international pharmaceutical group listed on the Italian Stock Exchange. With roots tracing back to a family pharmacy in Northern Italy in the 1920s, the company specializes in therapeutic options for specialty and general medicine, as well as rare diseases. Recordati operates in approximately 150 countries across the EMEA, Americas, and APAC regions, employing over 4,450 people. The company is committed to addressing common health challenges and rare diseases, emphasizing health as a fundamental right.

YTD Price Performance: 3.36%

Average Trading Volume: 34,294

Technical Sentiment Consensus Rating: Sell

Current Market Cap: €10.79B

For an in-depth examination of REC stock, go to TipRanks’ Stock Analysis page.